Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glyqa is a medical technology company based in London, United Kingdom, specializing in the development of non-invasive glucose monitoring solutions for individuals with diabetes. The company's core innovation is a proprietary sensing technology designed to measure blood glucose levels through the skin without the need for finger-prick blood samples or invasive sensors. By providing a painless and continuous monitoring experience, Glyqa aims to improve patient adherence to glucose management protocols and enhance overall quality of life. The company is currently focused on the research and development phase, working toward clinical validation and regulatory approval of its wearable device. Glyqa's technology represents a potential shift in the diabetes care market, targeting a more user-friendly alternative to traditional monitoring methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glyqa.